HbA1c reduction with tirzepatide in people with type 2 diabetes: a mediation analysis using body weight loss as a factor

被引：0
|
作者：
Vilsboll, T. [1 ]
Nicolay, C. [2 ]
Malecki, M. [3 ]
Thieu, V. Thuyanh [2 ]
Chivukula, K. [2 ]
Kiljanski, J. [2 ]
机构：
[1] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Ctr Clin Metab Res, Herlev, Denmark
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Jagiellonian Univ, Dept Metab Dis, Med Coll, Krakow, Poland
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
643
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [1] The Relationship between Weight Loss and HbA1c in People with Type 2 Diabetes
    Shinde, Shraddha
    Thieu, Vivian
    Kwan, Anita
    Houghton, Katherine F.
    Schapiro, David
    Meyers, Juliana
    DIABETES, 2022, 71
  • [2] Managing Type 2 Diabetes: Balancing HbA1c and Body Weight
    Mavian, Annie A.
    Miller, Stephan
    Henry, Robert R.
    POSTGRADUATE MEDICINE, 2010, 122 (03) : 106 - 117
  • [3] The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
    Gelhorn, Heather L.
    Osumili, Beatrice
    Brown, Katelyn
    Ross, Melissa M.
    Schulz, Andrea
    Fernandez, Gabriela
    Boye, Kristina S.
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 793 - 805
  • [4] THE IMPACT OF SUBSTANTIAL IMPROVEMENTS IN HBA1C AND WEIGHT LOSS ON THE MEDICATION PREFERENCES OF PEOPLE WITH TYPE 2 DIABETES
    Gelhorn, H.
    Osumili, B.
    Brown, K.
    Ross, M.
    Schulz, A.
    Fernandez, G.
    Boye, K.
    VALUE IN HEALTH, 2023, 26 (06) : S312 - S313
  • [5] Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes
    Overgaard, V. Rune
    Hertz, L. Christin
    Ingwersen, H. Steen
    Navarria, Andrea
    Drucker, J. Daniel
    CELL REPORTS MEDICINE, 2021, 2 (09)
  • [6] Glycemic Control with Tirzepatide in People with Type 2 Diabetes by Baseline HbA1c=8.5% or >8.5%
    Aleppo, Grazia
    De Block, Christophe
    Levine, Joshua A.
    Gomez-Valderas, Elisa
    Benneyworth, Brian D.
    DIABETES, 2022, 71
  • [7] In type 2 diabetes, tirzepatide reduced HbA1c vs. semaglutide
    Gandhi, Gunjan Y.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : JC127 - JC127
  • [8] Survival as a function of HbA1c in people with type 2 diabetes
    Riveline, Jean-Pierre
    Roussel, Ronan
    Mohammedi, Kamel
    LANCET, 2010, 375 (9724): : 1433 - 1433
  • [9] Survival in people with type 2 diabetes as a function of HbA1c
    Balkau, Beverley
    Simon, Dominique
    LANCET, 2010, 375 (9713): : 438 - 440
  • [10] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
12345